目次

TABLE OF CONTENT

1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.2.1 Inclusions and Exclusions of the Study
1.2.2 Markets Covered
1.2.3 Years Considered for the Study
1.3 Currency
1.4 Limitations
1.5 Stakeholders

2 Research Methodology
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Breakdown of Primaries
2.1.2.3 Key Industry Insights
2.2 Market Size Estimation
2.3 Market Breakdown & Data Triangulation
2.4 Market Share Estimation
2.5 Assumptions for the Study

3 Executive Summary

4 Premium Insights
4.1 Diagnostic Contract Manufacturing Market Overview
4.2 Diagnostic Contract Manufacturing Market: Geographic Mix
4.3 Diagnostic Contract Manufacturing Market , By Region (2023-2028)
4.4 Diagnostic Contract Manufacturing Market: Developed Vs. Developing Markets

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.2 Restraints
5.2.3 Opportunities
5.2.4 Challenges
5.3 Regulatory Analysis
5.3.1 Regulatory Landscape
5.3.2 Regulatory Bodies, government agencies and other organization
5.5 Porter's Five Force Analysis
5.6 Supply Chain Analysis
5.7 Ecosystem Mapping
5.8 Technology Analysis
5.9 Key Conferences and events in 2022-2023

6 Diagnostic Contract Manufacturing , By Device Type
6.1 Introduction
6.2 In Vitro Diagnostic Devices
6.2.1 IVD Consumables
6.2.2 IVD Equipment
6.3 Diagnostic Imaging Devices
6.3.1 X-ray
6.3.2 CT scan
6.3.3 Ultrasound
6.3.4 MRI
6.3.5 Others
6.4 Other Devices

7 Diagnostic Contract Manufacturing , By Service
7.1 Introduction
7.2 Device Development and Manufacturing Services
7.3 Quality Management Services
7.4 Packaging and Assembly Services
7.5 Other Services

8 Diagnostic Contract Manufacturing , By Application
8.1 In Vitro Diagnostic Devices
8.1.1 Infectious Diseases
8.1.2 Diabetes
8.1.3 Oncology
8.1.4 Cardiology
8.1.5 Others
8.2 Diagnostic Imaging Devices
8.2.1 Cardiology
8.2.2 Neurology
8.2.3 Orthopedics
8.2.4 Oncology
8.2.5 Others
8.3 Other Devices
8.3.1 Gastroenterology
8.3.2 Gynecology
8.3.3 Others

9 Diagnostic Contract Manufacturing , By Region
9.1 Introduction
9.2 North America
9.2.1 Recession Impact
9.2.2 US
9.2.3 Canada
9.3 Europe
9.3.1 Recession Impact
9.3.2 Germany
9.3.3 France
9.3.4 UK
9.3.5 Italy
9.3.6 Spain
9.3.7 Rest of Europe
9.4 Asia Pacific
9.4.1 Recession Impact
9.4.2 Japan
9.4.3 China
9.4.4 India
9.4.5 Rest of Asia Pacific
9.5 Rest of the World
9.5.1 Recession Impact

10 Competitive Landscape
10.1 Overview
10.2 Key Player Strategies
10.3 Revenue Share Analysis of Top Market Players
10.4 Market Share Analysis 2022
10.5 Company Evaluation Quadrant
10.5.1 Stars
10.5.2 Emerging leaders
10.5.3 Pervasive players
10.5.4 Participants
10.6 Product and Geographical Footprint Analysis of Top Players
10.7 Company Geographic footprint
10.8 Competitive Situation and Trends
10.8.1 Product launches and regulatory approvals
10.8.2 Key deals
10.8.3 Other developments

11 Company Profiles
11.1 Key Players
11.1.1 Jabil Inc.
11.1.2 Plexus Corp.
11.1.3 Sanmina Corporation
11.1.4 TE Connectivity
11.1.5 Celestica Inc.
11.1.6 Integer Holdings Corporation
11.1.7 Nipro Medical Corporation
11.1.8 Thermo Fisher Scientific
11.1.9 West Pharmaceutical Services, Inc.
11.1.10 Benchmark Electronics Inc.
11.1.11 Kimball Electronics Inc.
11.1.12 KMC Systems
11.1.13 Savyon Diagnostics
11.1.14 Nova Biomedical
11.2 Other Players
11.2.1 Cenogenic Corporation
11.2.2 Cone Bioproducts
11.2.3 Avioq Inc.
11.2.4 Philips-Medisize Corporation
11.2.5 Invetech
11.2.6 Meridian Bioscience, Inc.
11.2.7 Nolato AB
11.2.8 Fujirebio
11.2.9 Sekisui
11.2.10 Prestige Diagnostics
11.2.11 Biokit

12 Appendix
12.1 Discussion Guide
12.2 Knowledge Store: MarketsandMarkets- Subscription Portal
12.3 Available Customizations
12.4 Related Reports
12.5 Author Details